Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| adipocyte | 9 studies | 46% ± 12% | |
| astrocyte | 6 studies | 30% ± 15% | |
| endothelial cell | 5 studies | 30% ± 7% | |
| oligodendrocyte | 5 studies | 22% ± 9% | |
| epithelial cell | 4 studies | 29% ± 8% | |
| fibroblast | 3 studies | 34% ± 14% | |
| pericyte | 3 studies | 30% ± 13% | |
| hepatocyte | 3 studies | 54% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 100% | 2910.99 | 328 / 328 | 100% | 17.02 | 178 / 178 |
| esophagus | 100% | 1579.57 | 1444 / 1445 | 100% | 22.81 | 183 / 183 |
| bladder | 100% | 1227.05 | 21 / 21 | 100% | 20.46 | 503 / 504 |
| liver | 100% | 18714.65 | 226 / 226 | 100% | 40.69 | 405 / 406 |
| lung | 99% | 1683.60 | 575 / 578 | 100% | 21.18 | 1155 / 1155 |
| intestine | 100% | 1589.71 | 963 / 966 | 100% | 23.47 | 525 / 527 |
| stomach | 100% | 2787.15 | 359 / 359 | 99% | 22.59 | 284 / 286 |
| breast | 100% | 4055.07 | 459 / 459 | 99% | 19.63 | 1110 / 1118 |
| prostate | 100% | 1585.40 | 244 / 245 | 100% | 18.25 | 500 / 502 |
| brain | 99% | 1651.61 | 2620 / 2642 | 100% | 12.98 | 705 / 705 |
| uterus | 100% | 1621.61 | 170 / 170 | 98% | 16.98 | 452 / 459 |
| thymus | 100% | 1923.36 | 653 / 653 | 98% | 12.03 | 595 / 605 |
| kidney | 100% | 2271.97 | 89 / 89 | 98% | 15.68 | 884 / 901 |
| skin | 100% | 2225.76 | 1807 / 1809 | 94% | 12.52 | 443 / 472 |
| ovary | 100% | 2973.59 | 180 / 180 | 94% | 11.25 | 403 / 430 |
| adrenal gland | 100% | 2200.22 | 258 / 258 | 92% | 17.17 | 211 / 230 |
| adipose | 100% | 4812.22 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 20.08 | 29 / 29 |
| spleen | 100% | 1250.28 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 12.69 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 8.08 | 1 / 1 |
| blood vessel | 97% | 1075.75 | 1291 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 89% | 1046.36 | 716 / 803 | 0% | 0 | 0 / 0 |
| heart | 83% | 700.24 | 718 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 74% | 5.84 | 59 / 80 |
| peripheral blood | 48% | 1028.22 | 450 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0060561 | Biological process | apoptotic process involved in morphogenesis |
| GO_2001241 | Biological process | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| GO_0006470 | Biological process | protein dephosphorylation |
| GO_0000159 | Cellular component | protein phosphatase type 2A complex |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005829 | Cellular component | cytosol |
| GO_0045121 | Cellular component | membrane raft |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0019888 | Molecular function | protein phosphatase regulator activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PPP2R1B |
| Protein name | Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform (PP2A subunit A isoform PR65-beta) (PP2A subunit A isoform R1-beta) Protein phosphatase 2 scaffold subunit Abeta |
| Synonyms | |
| Description | FUNCTION: The PR65 subunit of protein phosphatase 2A serves as a scaffolding molecule to coordinate the assembly of the catalytic subunit and a variable regulatory B subunit. |
| Accessions | H0YDG7 ENST00000534500.5 E9PHZ6 E9PNM7 ENST00000393055.6 [P30154-5] P30154 ENST00000426998.6 [P30154-3] ENST00000534521.5 ENST00000527614.6 [P30154-1] E9PPI5 ENST00000531890.1 ENST00000531373.1 ENST00000341980.10 [P30154-4] ENST00000311129.9 [P30154-2] |
